Category: neuroendocrine tumors
Fortune Reports That Steve Jobs Sought Neuroendocrine Cancer Treatment in Switzerland
Fortune reported today, January 18, 2011, that Apple’s CEO Steve Jobs went to Basel, Switzerland in 2009 seeking treatment for neuroendocrine cancer. Read the story HERE.…
READ MORESteve Jobs to Take New Medical Leave from Apple
Steve Jobs, CEO and co-founder of Apple and the most well-known member of the carcinoid and neuroendocrine tumor community, is taking a new medical leave of absence. This announcement was reported today, January 17, 2011, by The New York Times, a year…
READ MOREVideos from 2010 Vancouver International Carcinoid & NET Cancer Conference Now Online
Maureen Coleman, President of CNETS Canada, has announced that videos from the May 2010 international carcinoid and NET cancer conference for patients and medical professionals are now online at http://cnetscanada.org. According to Ms. Coleman,…
READ MOREBreaking News from Canada about Carcinoid and Neuroendocrine Cancer Awareness
For the first time in the history of Canada’s Federal Parliament, a member of the House of Commons has taken the floor to speak about the need for awareness of neuroendocrine cancer. On Tuesday, November 2nd, the Honorable, Dr. Carolyn Bennett, PC, MP…
READ MOREGovernors of Louisiana and Montana Join Worldwide NET Cancer Awareness Campaign
Governor Bobby Jindal of Louisiana and Governor Brian Schweitzer of Montana have become the 6th and 7th United States governors to pledge their support to the first Worldwide NET Cancer Awareness Day on November 10, 2010. Governor Schweitzer wrote,…
READ MORECanada’s Dufferin County Council Proclaims Worldwide NET Cancer Awareness Day
The Dufferin County Council in Ontario, Canada, has named November 10th as Worldwide NET Cancer Awareness Day. This is the first municipal proclamation for the Worldwide NET Cancer Awareness Day in Ontario and in Canada. All members of the council signed…
READ MORE2012 National Carcinoid & NETs Conference: Save the Date
Dr. Eugene A. Woltering, the Carcinoid Cancer Awareness Network (CCAN), and the New Orleans Neuroendocrine Tumor Specialist team at Ochsner Medical Center – Kenner in Louisiana have announced the dates for the 2012 National Carcinoid/NETs Conference…
READ MOREFDA Approves Novel Radio-peptide Targeted Therapy Clinical Trial for Neuroendocrine Cancer: PRRT (Peptide Receptor Radionuclide Therapy)
For the first time in North America, neuroendocrine cancer patients will have the opportunity to participate in a clinical trial of Lutetieum-177 (LU-177)with Octreotate. Ebrahim S. Delpassand, MD, chief executive officer and medical director of…
READ MORE10 More iPhone Apps for Patients and Physicians
If you are a carcinoid or neuroendocrine cancer iPhone user, a healthcare provider who treats carcinoid/NETs patients, or a medical student, here are 10 more iPhone apps that will give you information about everything from new drug warnings to places…
READ MORECarcinoid Cancer Foundation Welcomes Channeling Jackie-O
When Marlena Johnston was first diagnosed with carcinoid cancer of the appendix in April 2010, she went to the Carcinoid Cancer Foundation’s website and embarked on a journey to learn all she could about her rare disease. She began with Newly Diagnosed:…
READ MORE